Zydus Seeks DCGI Approval For Clinical Trial Of Monoclonal Antibodies Cocktail

Zydus Cadila on Thursday announced that its biological therapy ZRC-3308, a cocktail of two SARS-CoV-2-neutralizing monoclonal antibodies (mAbs) can emerge as one of the main treatments for mild COVID-19. ....

 

Full Story

Covid Patients Relieved Of Symptoms In 24 Hours After Taking Antibody Cocktail

Fifty Covid-19 patients who received single-dose monoclonal antibodies cocktail drug (casirivimab and imdevimab) were relieved of their symptoms within 24 hours of the therapy given at the AIG Hospitals in Hyderabad. ....

 

Full Story